Michelle O'connor
About Michelle O'connor
Michelle O'Connor is a Principal Scientist at Lyndra Therapeutics, where she has worked since 2021. She has previous experience at Moderna Therapeutics and Novartis Vaccines and Diagnostics, contributing to her expertise in the field.
Work at Lyndra Therapeutics
Michelle O'Connor has been serving as Principal Scientist at Lyndra Therapeutics since 2021. In this role, she contributes to the development of innovative drug delivery systems aimed at improving patient adherence. Prior to her current position, she worked as a Senior Scientist at the same organization from 2019 to 2021, where she focused on advancing research initiatives that align with the company’s mission to transform medicine.
Previous Experience at Moderna Therapeutics
Before joining Lyndra Therapeutics, Michelle O'Connor worked at Moderna Therapeutics as a Senior Research Associate from 2014 to 2017. During her time in Cambridge, Massachusetts, she was involved in research efforts that supported the development of mRNA-based therapeutics, contributing to the company's innovative approach to vaccine and therapeutic development.
Experience at Novartis Vaccines and Diagnostics
Michelle O'Connor held the position of Associate Scientist III at Novartis Vaccines and Diagnostics, Inc. from 2012 to 2014. Based in Cambridge, Massachusetts, she engaged in vaccine research and diagnostics, contributing to projects that aimed to enhance public health through effective immunization strategies.
Career Progression
Michelle O'Connor's career reflects a steady progression in the field of biotechnology and pharmaceuticals. Starting as an Associate Scientist at Novartis, she advanced to a Senior Research Associate at Moderna, and later to Senior Scientist at Lyndra Therapeutics. Her experience spans various aspects of research and development, showcasing her expertise in drug delivery and vaccine development.